<p>Atezolizumab is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (UC):</p>

<ul>
	<li>After prior chemotherapy, or</li>
	<li>Who are considered cisplatin ineligibleand whose tumours have a PD-L1 expression &ge; 5%, or</li>
	<li>Who are not eligible for any platinum-containing chemotherapy regardless of level of tumor PD-L1 expression.</li>
</ul>

<p>Atezolizumab is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer NSCLC after prior chemotherapy.</p>